Influence of interferon (IFN)-based therapy on liver fibrosis progression (LFP) in HIV/HCV co-infected patients

被引：0
|
作者：
Benhamou, Yves
Valentin, Marc Antoine
Dominguez, Stephanie
Varastet, Marina
Zin, Adeline
Katlama, Christine
Poynard, Thierry
机构：
[1] Hop La Pitie Salpetriere, F-75013 Paris, France
[2] ClinSearch, Bagneux, France
来源：
HEPATOLOGY | 2007年 / 46卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1372
引用
收藏
页码：849A / 849A
页数：1
相关论文
共 50 条
  • [21] Liver disease progression in HIV/HCV co-infected patients: a role for metalloproteinases and their specific inhibitors
    Sasongko, Priyo
    RETROVIROLOGY, 2006, 3
  • [22] Presence of multiple HCV genotypes and response to interferon-ribavirin therapy HIV/HCV co-infected patients
    Bonacini, M
    Bzowej, N
    Phuong, Y
    HEPATOLOGY, 2004, 40 (04) : 409A - 409A
  • [23] SEVERITY OF LIVER STEATOSIS AFFECTS PROGRESSION OF DISEASE IN MONOINFECTED PATIENTS BUT NOT IN HCV/HIV CO-INFECTED PATIENTS
    Rodriguez-Torres, Maribel
    Brau, Norbert
    Rodriguez-Orengo, Jose F.
    Ortiz-Lasanta, Grisell
    Segarra-Alonso, Omar
    Marxuach, Acisclo M.
    HEPATOLOGY, 2009, 50 (04) : 1060A - 1060A
  • [24] Time on antiretroviral therapy is a protective factor for liver fibrosis in HIV and hepatitis C virus (HCV) co-infected patients
    Tural, C
    Fuster, D
    Tor, J
    Ojanguren, I
    Sirera, G
    Ballesteros, A
    Lasanta, JAJ
    Planas, R
    Rey-Joly, C
    Clotet, B
    JOURNAL OF VIRAL HEPATITIS, 2003, 10 (02) : 118 - 125
  • [25] The effects of a maintenance therapy with peg-interferon alpha-2a on liver fibrosis in HIV/HCV co-infected patients: A randomized controlled trial
    Chapplain, Jean-Marc
    Bellissant, Eric
    Guyader, Dominique
    Molina, Jean-Michel
    Poizot-Martin, Isabelle
    Perre, Philippe
    Pialoux, Gilles
    Turlin, Bruno
    Mouchel, Catherine
    Renault, Alain
    Michelet, Christian
    JOURNAL OF INFECTION, 2013, 67 (04) : 313 - 321
  • [26] EFFECT OF HCV THERAPY ON IMMUNOLOGICAL HOMEOSTASIS IN HIV/HCV CO-INFECTED PATIENTS
    Airoldi, M.
    Nasta, P.
    Maggiolo, F.
    Di Gianbenedetto, S.
    Ladisa, N.
    Gatti, F.
    Suter, F.
    Fabbiani, M.
    Bandera, A.
    Gori, A.
    INFECTION, 2011, 39 : S78 - S78
  • [27] Accelerated hepatic fibrosis progression in HIV and HCV co-infected patients may be predicted by ALT.
    Mohsen, AH
    Taylor, C
    Kulasegaram, R
    Portmann, B
    HEPATOLOGY, 2002, 36 (04) : 349A - 349A
  • [28] Does HIV-1 co-receptor tropism correlate with fibrosis progression in HIV/HCV co-infected patients?
    Saracino, A.
    Bruno, G.
    Scudeller, L.
    Punzi, G.
    Lagioia, A.
    Ladisa, N.
    Monno, L.
    Angarano, G.
    JOURNAL OF CLINICAL VIROLOGY, 2014, 59 (03) : 167 - 171
  • [29] Assessment of liver cirrhosis by elastography in HCV/HIV co-infected patients
    Castellares, C.
    Martin-Carbonero, L.
    Barreiro, P.
    Ramos, B.
    Sheldon, J.
    Labarga, P.
    Novoa-Rodriguez, S.
    Gonzalez-Lahoz, J.
    Soriano, V.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S544 - S545
  • [30] PROSPECTIVE EVALUATION BY PAIRED LIVER BIOPSY OF HCV DISEASE PROGRESSION IN PATIENTS (PTS) CO-INFECTED WITH HIV
    Sterling, Richard K.
    Smith, Paula G.
    Wegelin, Jacob
    Shiffman, Mitchell L.
    Stravitz, Richard T.
    Luketic, Velimir A.
    Fuchs, Michael
    Sanyal, Arun J.
    HEPATOLOGY, 2008, 48 (04) : 321A - 321A
12345